" class="no-js "lang="en-US"> News Archives - Medtech Alert
Sunday, March 26, 2023

Sort by:

Date

Top Post

Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa

Illumina, a global leader in DNA sequencing and array-based technologies, and GenoScreen, an innovative genomics […]

Celyad Oncology Appoints Georges Rawadi as Its New CEO

Celyad Oncology, a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell […]

Companion Spine Closes $60.1 Million Series A Funding Round

Companion Spine, the French-American specialist in interventional spine pain-management surgery, today announced the successful closing […]

Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer

Vividion Therapeutics, a biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets […]

GT Medical Technologies Raises $45 Million in Oversubscribed Series C Financing Led by Gilde Healthcare

GT Medical Technologies, a medical device company dedicated to improving the lives of patients with […]

Genprex CEO Commends FDA's Initiative to Accelerate Approval Process for Gene Therapies

Rodney Varner, CEO of Genprex, a clinical-stage gene therapy company focused on developing life-changing therapies […]

OliX Pharmaceuticals Receives Regulatory Approval to Commence Phase 1 Clinical Trial of Treatment of Androgenic Alopecia

OliX Pharmaceuticals, a leading developer of RNAi therapeutics, announced today that it has received approval […]

Bayer Expands Global Clinical Program for NUBEQA® (darolutamide) in Prostate Cancer

Bayer further expands the global clinical development program for NUBEQA (darolutamide) in prostate cancer. The […]

BIOTECanada Welcomes Government of Canada’s Strategy on Improving Access to Care for Patients with Rare Diseases

BIOTECanada welcomes the government’s dedicated investment of $1.5 B over 3 years to advance effective […]

  1. Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
  2. Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
  3. Companion Spine Closes $60.1 Million Series A Funding Round Read more
  4. EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
  5. Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more